Seroatlas · Human Serome Atlas

SPINT2

Kunitz-type protease inhibitor 2

Also known as: HAI-2, HAI2, Kop, SPIT2_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
O43291
Gene
SPINT2
Ensembl
ENSG00000167642
Chromosome
19
Canonical length
252 aa
Protein class
Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
Subcellular location
Golgi apparatus,Vesicles

OverviewNCBI Gene

This gene encodes a transmembrane protein with two extracellular Kunitz domains that inhibits a variety of serine proteases. The protein inhibits HGF activator which prevents the formation of active hepatocyte growth factor. This gene is a putative tumor suppressor, and mutations in this gene result in congenital sodium diarrhea. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]

Canonical amino-acid sequenceUniProt

252 residues, UniProt reviewed canonical sequence.

>O43291|SPINT2
     1  MAQLCGLRRS RAFLALLGSL LLSGVLAADR ERSIHDFCLV SKVVGRCRAS MPRWWYNVTD
    61  GSCQLFVYGG CDGNSNNYLT KEECLKKCAT VTENATGDLA TSRNAADSSV PSAPRRQDSE
   121  DHSSDMFNYE EYCTANAVTG PCRASFPRWY FDVERNSCNN FIYGGCRGNK NSYRSEEACM
   181  LRCFRQQENP PLPLGSKVVV LAGLFVMVLI LFLGASMVYL IRVARRNQER ALRTVWSSGD
   241  DKEQLVKNTY VL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against SPINT2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.44
Highest tissue expression
475 nTPM

Expression across tissuesHPA

Tissue

  • salivary gland: 475 nTPM
  • pituitary gland: 409 nTPM
  • blood vessel: 334 nTPM
  • esophagus: 334 nTPM
  • thyroid gland: 301 nTPM
  • colon: 278 nTPM

Single-cell type

  • enterocytes: 120 nCPM
  • endometrial glandular cells: 86 nCPM
  • esophageal apical cells: 68 nCPM
  • late primary spermatocytes: 66 nCPM
  • colonocytes: 65 nCPM
  • urothelial cells: 61 nCPM

Immune cell

  • eosinophil: 533 nTPM
  • plasmacytoid DC: 525 nTPM
  • basophil: 519 nTPM
  • myeloid DC: 298 nTPM
  • naive B-cell: 161 nTPM
  • memory B-cell: 144 nTPM

Brain region

  • hypothalamus: 139 nTPM
  • choroid plexus: 113 nTPM
  • cerebral cortex: 66 nTPM
  • basal ganglia: 62 nTPM
  • pons: 61 nTPM
  • midbrain: 60 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about SPINT2.

Disease | AllUniProt

Conditions SPINT2 is implicated in, by any mechanism.

Disease | GeneticClinVar

17 pathogenic / likely-pathogenic of 213 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.98
gnomAD pLI
0
gnomAD missense Z
1
DepMap mean gene effect
-0.17
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of SPINT2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads SPINT2 as an antibody target. Whether an autoantibody or antibody against SPINT2 could matter depends on whether native SPINT2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

SPINT2 is annotated at the cell surface, where native SPINT2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label SPINT2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/SPINT2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...